ABT
Abbott Soars into Q1 2026 with Strong Earnings and Strategic Milestones
Abbott, a leading global healthcare company, has reported strong first-quarter (Q1) 2026 earnings and achieved several strategic milestones in its medical device business. The company's adjusted earnings per share came in at $1.15, meeting its guidance despite absorbing the impact of earlier-than-planned financing costs related to the